Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Medicine UCSF Medical Center
Home

Main navigation

  • About Us
    • Administration
    • Calendar
    • History / Chiefs
  • Faculty
  • Education
    • Continuing Medical Education
    • Medical Students
    • Residents
    • Visiting Faculty
    • Mentoring
  • Fellowship
    • Program Overview
    • Program Tracks
      • Research Track
      • Clinician Educator Track
    • Program Subtracks
      • Antimicrobial Stewardship/Hospital Epidemiology and Infection Prevention Track
      • Transplant ID Track
      • HIV Track
      • Addiction Medicine Track
    • Clinical Experiences
    • Curriculum
    • CORE
    • Fellow Well-Being
    • Life in ID Fellowship
    • Current Fellows
    • Fellowship Application Process
    • Recent Graduates
  • Patient Care
    • For Patients
      • Dysplasia
      • HIV
      • Infectious Disease Clinic
      • Neuro
      • Transplant
  • Research
  • Giving

Breadcrumb

  1. People
  2. B Joseph Guglielmo, PharmD
Image of B Joseph Guglielmo, PharmD
  • Send an Email
  • +1 415 476-8010

513 Parnassus Avenue, Rm 126 UCSF Box 0403 San Francisco, CA 94117

View UCSF Profile

B Joseph Guglielmo, PharmD

Professor Emeritus

B. Joseph Guglielmo, PharmD, is a pharmacist, clinical scientist, teacher, and international expert in the evidence-based use of antimicrobials to treat infections.

He was named dean of the UCSF School of Pharmacy in 2012 and holds the Troy C. Daniels Distinguished Professorship in Pharmaceutical Science.

As dean, Guglielmo oversees the activities and progress of three departments; a campus organized research unit; and a dean’s office charged with School administration and finance, strategic planning, communications, academic affairs, and the development and delivery of a doctor of pharmacy (PharmD) degree program. His leadership as dean actively supports the distinguishing UCSF concept of One UCSF and upholds the institution’s PRIDE values.

During his tenure as dean, the School of Pharmacy has remained the top recipient among pharmacy schools nationwide of research dollars from the National Institutes of Health (NIH), and its PharmD degree program has remained among the top-rated such programs in the nation.

Guglielmo initiated a transformation of the PharmD degree program, which welcomed its first class in 2018. The program’s foundation of scientific thinking evolves from the distinctive scientific mindset of the faculty, and the faculty’s drive to seek and apply new knowledge across research, education, and patient care.

Guglielmo is widely known as an advocate for therapeutics-related research, from basic science to health policy research. As chair of the School's Department of Clinical Pharmacy, Guglielmo oversaw a 40 percent increase in the Department of Clinical Pharmacy’s faculty research funding. He created the department-run Medication Outcomes Center in 2007 to improve medication use at UCSF Health and beyond. In the late 1980s he developed the UCSF Medical Center Antimicrobial Stewardship Program to ensure the safe, effective use of antimicrobials, focusing upon decreasing antimicrobial resistance. The program was one of the earliest programs of its kind in the United States.

As patients seek new and cost-effective health care with increasingly complicated disease states and medications, Guglielmo advocates for research on new ways for pharmacists to care for patients, especially in the community. He also supports strong relationships among clinical scientists and their upstream basic and translational scientist colleagues, as demonstrated through his own collaborations. Guglielmo has been actively involved in the UCSF Clinical and Translational Science Institute (CTSI) from its inception and during its renewal; he has also served as past associate director of the CTSI Mentor Development Program.

His personal research agenda involves the safe, effective, and appropriate use of antimicrobials, as well as the pharmacoepidemiology and pharmacokinetics of anti-infective agents. He is the author of numerous peer-reviewed papers, book chapters, and abstracts, the majority related to anti-infective agents.

He believes that the most important clinical research is shaped through the researcher’s own clinical experiences. Together with his administrative, research, and teaching responsibilities, he continues to be active as an infectious diseases pharmacist supporting the UCSF Medical Center Antimicrobial Stewardship Program and serving on the Infectious Diseases Consult Service team. These experiences continue to provide the background for important hypothesis-centered research on the safe, effective use of antimicrobials.

Beyond the hospital, Guglielmo developed clinical pharmacy services for UCSF HIV/AIDS programs, specifically for the HIV Women's Program and the Men of Color Program.

Guglielmo has taught doctor of pharmacy students, pharmacy residents and fellows, medical students and residents, and infectious diseases fellows for decades, and he has mentored infectious diseases specialty pharmacist residents and fellows continuously since 1986. He has also mentored a number of international scholars, including Fogarty fellows.

He is the recipient of many teaching awards, including the UCSF Lifetime Achievement in Mentoring Award, Resident Preceptor of the Year Awards, UCSF School of Pharmacy Long Teaching Awards, and UCSF Academic Senate Distinction in Teaching Award. He is a fellow of the American College Clinical Pharmacy and the Infectious Diseases Society of America.


Guglielmo earned a PharmD from the University of Southern California in 1978 and completed a PharmD residency at UCSF in 1979.
Education
Residency, 1979 - School of Pharmacy - Pharmacy Practice, University of California, San Francisco
PharmD, 1978 - Pharmacy, University of Southern California (USC)
B.S., 1973 - Biology, Santa Clara University
Honors and Awards
  • Fellow, Infectious Diseases Society America, 2013
  • Troy C. Daniels Distinguished Professorship in Pharmaceutical Science, UCSF, 2013
  • Fellow, American College of Clinical Pharmacy, 2011
  • Faculty Mentoring Program Lifetime Achievement in Mentoring Award, UCSF, 2010
  • Vincent G. Pons Award in Clinical Infectious Diseases, UCSF, 2005
  • Long Prize for Excellence in Teaching, UCSF, 1999
  • Pharmacy Leadership Society Recognition, Phi Lambda Sigma, 1995
  • Pharmacy Residents Preceptorship Award, UCSF, 1995
  • Fellow, California Society of Health-System Pharmacists, 1993
  • Academic Senate Distinction in Teaching Award, UCSF, 1992
  • Commencement Speaker, School of Pharmacy, UCSF, 1992
  • Pharmacy Residents Preceptorship Award, UCSF, 1989
  • Pharmacy Residents Preceptorship Award, UCSF, 1988
  • Pharmacy Residents Preceptorship Award, UCSF, 1987
  • Long Foundation Award for Excellence in Teaching, UCSF, 1986
  • Pharmacy Residents Preceptorship Award, UCSF, 1985
  • Long Foundation Award for Excellence in Teaching, UCSF, 1981
  • Pharmacy Residents Preceptorship Award, UCSF, 1981
Websites
  • UCSF School of Pharmacy Website
  • Profile at UCSF School of Pharmacy
Publications
  1. Shehu D, Kim MO, Rosendo J, Krogan N, Morgan DO, Guglielmo BJ. Institutional Conversion to Energy-Efficient Ultra-Low Freezers Decreases Carbon Footprint and Reduces Energy Costs. 2024. PMID: 39321093


  2. Guglielmo BJ. Metronidazole Neurotoxicity: Suspicions Confirmed. 2021. PMID: 32266372


  3. Guglielmo BJ. The Colchicine Debacle Revisited. 2021. PMID: 33252611


  4. Guglielmo BJ. The Cost of Pharmaceutical Company Detailing Visits and Medication Samples. 2020. PMID: 31985770


  5. Meyer-Massetti C, Hofstetter V, Hedinger-Grogg B, Meier CR, Guglielmo BJ. Medication-related problems during transfer from hospital to home care: baseline data from Switzerland. 2018. PMID: 30291577


  6. Meyer-Massetti C, Meier CR, Guglielmo BJ. The scope of drug-related problems in the home care setting. 2018. PMID: 29322475


  7. Woldu H, Guglielmo BJ. Incidence and risk factors for vancomycin nephrotoxicity in acutely ill pediatric patients 2018. PMID:


  8. Woldu H, Guglielmo BJ. Incidence and Risk Factors for Vancomycin Nephrotoxicity in Acutely Ill Pediatric Patients. 2017. PMID: 34860973


  9. Roy SL, Atkins JT, Gennuso R, Kofos D, Sriram RR, Dorlo TP, Hayes T, Qvarnstrom Y, Kucerova Z, Guglielmo BJ, Visvesvara GS. Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain. 2015. PMID: 26329128


  10. Cheng CM, Shin J, Guglielmo BJ. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012. 2014. PMID: 25127107


  11. Hardmeier A, Tsourounis C, Moore M, Abbott WE, Guglielmo BJ. Pediatric medication administration errors and workflow following implementation of a bar code medication administration system. 2014. PMID: 25041604


  12. Gahbauer AM, Gonzales ML, Guglielmo BJ. Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort. 2014. PMID: 24753176


  13. Tan M, Lau J, Guglielmo BJ. Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. 2014. PMID: 24554477


  14. Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. 2013. PMID: 23652479


  15. Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo BJ, Sun Y, Verotta D. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. 2013. PMID: 23702622


  16. Gwaza L, Aweeka F, Greenblatt R, Lizak P, Huang L, Guglielmo BJ. Co-administration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir. 2013. PMID: 23587599


  17. Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. 2013. PMID: 23553582


  18. Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo BJ. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. 2013. PMID: 24421479


  19. Guglielmo BJ. The colchicine debacle. 2013. PMID: 23277277


  20. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ. Improved antiretroviral refill adherence in HIV-focused community pharmacies. 2012. PMID: 23023860


  21. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. 2012. PMID: 22860900


  22. Swartling M, Gupta R, Dudas V, Guglielmo BJ. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. 2012. PMID: 22331444


  23. Cheng CM, Fu C, Guglielmo BJ, Auerbach AD. Boxed warning inconsistencies between drug information resources and the prescribing information. 2011. PMID: 21856808


  24. Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. 2011. PMID: 21923588


  25. Guglielmo BJ, Edwards DJ, Franks AS, Naughton CA, Schonder KS, Stamm PL, Thornton P, Popovich NG. A critical appraisal of and recommendations for faculty development. 2011. PMID: 21931460


  26. Meyer-Massetti C, Vaerini S, Rätz Bravo AE, Meier CR, Guglielmo BJ. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. 2011. PMID: 21809143


  27. Cheng C, Guglielmo BJ. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling". 2011. PMID: 21606102


  28. Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, Guglielmo BJ. Systematic review of medication safety assessment methods. 2011. PMID: 21258028


  29. Macdougall C, Udkow T, Guglielmo BJ, Vittinghoff E, Martin J. National estimates and predictors of prescription medication sample use in the United States, 1999-2005. Volume 50 of Issue 6. 2010. PMID: 21071311


  30. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. 2010. PMID: 20605267


  31. Guglielmo BJ. A prescription for improved chronic disease management: have community pharmacists function at the top of their training: comment on "Engaging physicians and pharmacists in providing smoking cessation counseling". 2010. PMID: 20937923


  32. Cheng CM, Guglielmo BJ, Maselli J, Auerbach AD. Coverage of FDA medication boxed warnings in commonly used drug information resources. 2010. PMID: 20458094


  33. Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. 2010. PMID: 20192728


  34. Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo BJ. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? 2010. PMID: 20394022


  35. Koplowicz YB, Schwartz BS, Guglielmo BJ. Development of daptomycin-susceptible, methicillin-resistant Staphylococcus aureus pneumonia during high-dose daptomycin therapy. 2009. PMID: 19780665


  36. Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M, O'Malley R, Hwang J, Linker C. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. 2009. PMID: 19793068


  37. Feldman MD, Huang L, Guglielmo BJ, Jordan R, Kahn J, Creasman JM, Wiener-Kronish JP, Lee KA, Tehrani A, Yaffe K, Brown JS. Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. 2009. PMID: 19774102


  38. Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. 2009. PMID: 19295465


  39. Yang K, Zhuo H, Guglielmo BJ, Wiener-Kronish J. Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures. 2008. PMID: 19033484


  40. Marquez C, Guglielmo BJ, Klausner JD. Five years later: re-examining the financial burden of boosting with Norvir. 2008. PMID: 18981784


  41. Patel D, Lawson W, Guglielmo BJ. Antimicrobial stewardship programs: interventions and associated outcomes. 2008. PMID: 18380603


  42. Frenzel T, Lee CZ, Kim H, Quinnine NJ, Hashimoto T, Lawton MT, Guglielmo BJ, McCulloch CE, Young WL. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. 2008. PMID: 18212521


  43. Schwartz BS, Ngo PD, Guglielmo BJ. Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding? 2008. PMID: 18172014


  44. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. Volume 47 of Issue 5. 2007. PMID: 17848351


  45. Yang K, Guglielmo BJ. Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. 2007. PMID: 17666573


  46. Riedel A, Choe L, Inciardi J, Yuen C, Martin T, Guglielmo BJ. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study. 2007. PMID: 17605773


  47. Nicandro JP, Tsourounis C, Frassetto L, Guglielmo BJ. In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4. 2007. PMID: 17594986


  48. Huang Y, Okochi H, May BC, Legname G, Prusiner SB, Benet LZ, Guglielmo BJ, Lin ET. Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein. 2006. PMID: 16581945


  49. Schuster FL, Guglielmo BJ, Visvesvara GS. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. 2006. PMID: 16579814


  50. Deck DH, Guglielmo BJ. Pharmacological advances in the treatment of invasive candidiasis. 2006. PMID: 16441215


  51. Lee CZ, Yao JS, Huang Y, Zhai W, Liu W, Guglielmo BJ, Lin E, Yang GY, Young WL. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. 2006. PMID: 16395286


  52. Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections. 2006. PMID: 16509027


  53. Guglielmo BJ, Dudas V, Maewal I, Young R, Hilts A, Villmann M, Gibbs L, Gropper M, Jacobs R. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci. 2005. PMID: 16156195


  54. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R. Antimicrobial drug prescribing for pneumonia in ambulatory care. Volume 11 of Issue 3. 2005. PMID: 15757551


  55. Chang NN, Murray CK, Houck PM, Bratzler DW, Greenway C, Guglielmo BJ. Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia. 2005. PMID: 15767221


  56. Yung L, Huang Y, Lessard P, Legname G, Lin ET, Baldwin M, Prusiner SB, Ryou C, Guglielmo BJ. Pharmacokinetics of quinacrine in the treatment of prion disease. 2004. PMID: 15569390


  57. Killgore KM, March KL, Guglielmo BJ. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. 2004. PMID: 15150380


  58. MacDougall C, Guglielmo BJ. Pharmacokinetics of valaciclovir. Volume 53 of Issue 6. 2004. PMID: 15140857


  59. Bower AN, Tang HM, Guglielmo BJ. Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B. 2004. PMID: 15156967


  60. Oren E, Shaffer ER, Guglielmo BJ. Impact of emerging technologies on medication errors and adverse drug events. 2003. PMID: 12892029


  61. Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, Guglielmo BJ. Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. 2003. PMID: 12821497


  62. Hickman DE, Stebbins MR, Hanak JR, Guglielmo BJ. Pharmacy-based intervention to reduce antibiotic use for acute bronchitis. 2003. PMID: 12549944


  63. Oren E, Griffiths LP, Guglielmo BJ. Characteristics of antimicrobial overrides associated with automated dispensing machines. 2002. PMID: 12166045


  64. Yang K, Guglielmo BJ. Patient education for H pylori: who benefits? 2002. PMID: 11897729


  65. Graff LR, Franklin KK, Witt L, Cohen N, Jacobs RA, Tompkins L, Guglielmo BJ. Antimicrobial therapy of gram-negative bacteremia at two university-affiliated medical centers. 2002. PMID: 11893347


  66. Botwin KJ, Chan J, Jacobs R, Guglielmo BJ. Restricted access to automated dispensing machines for surgical antimicrobial prophylaxis. 2001. PMID: 11351920


  67. Burkiewicz JS, Kostiuk KA, Jacobs RA, Guglielmo BJ. Impact of an intravenous fluconazole restriction policy on patient outcomes. 2001. PMID: 11197590


  68. Dudas V, Hopefl A, Jacobs R, Guglielmo BJ. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. 2000. PMID: 10772428


  69. Guglielmo BJ, Luber AD, Paletta D, Jacobs RA. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. 2000. PMID: 10619757


  70. Guglielmo BJ, Luber AD, Corelli RL, Flaherty JF, Jacobs RA. Prevention of adverse events in hospitalized patients using an antimicrobial review program. 1999. PMID: 10560287


  71. Luber AD, Maa L, Lam M, Guglielmo BJ. Risk factors for amphotericin B-induced nephrotoxicity. 1999. PMID: 11252333


  72. Guglielmo BJ. Use of antimicrobial agents in patients with cardiovascular disease. 1999. PMID: 9888061


  73. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: clinical efficacy and toxicities. 1998. PMID: 9770163


  74. Guglielmo BJ, Kostiuk KA, Pons VG. Pharmacokinetics and pharmacodynamics of ceftizoxime in abscess fluid. 1997. PMID: 9096200


  75. Hashimoto S, Wolfe E, Guglielmo B, Shanks R, Sundelof J, Pittet JF, Thomas E, Wiener-Kronish J. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury. 1996. PMID: 8961050


  76. Barlows TG, Luber AD, Jacobs RA, Guglielmo BJ. Hypothermia following the intravenous administration of amphotericin B. 1996. PMID: 8922832


  77. Tsourounis C, Guglielmo BJ. Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis. 1996. PMID: 8893125


  78. Guglielmo BJ, Jacobs RA. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin. 1996. PMID: 8870902


  79. Guglielmo BJ, Quan LA, Stulbarg MS. Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients. 1996. PMID: 8737161


  80. Luber AD, Jacobs RA, Jordan M, Guglielmo BJ. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. 1996. PMID: 8627091


  81. Guglielmo BJ. Practical strategies for the appropriate use of antimicrobials. 1995. PMID: 7581222


  82. Wong-Beringer A, Corelli RL, Schrock TR, Guglielmo BJ. Influence of timing of antibiotic administration on tissue concentrations during surgery. 1995. PMID: 7694975


  83. Singh RF, Corelli RL, Guglielmo BJ. Sterility of unit dose syringes of filgrastim and sargramostim. 1994. PMID: 7531941


  84. Kostiuk KA, Pons VG, Guglielmo BJ. Penetration of fluconazole into abscess fluid. 1994. PMID: 7868415


  85. Guglielmo BJ, Wong-Beringer A, Linker CA. Immune globulin therapy in allogeneic bone marrow transplant: a critical review. 1994. PMID: 8054903


  86. Joe LA, Jacobs RA, Guglielmo BJ. Systemic absorption of oral fluconazole after gastrointestinal resection. 1994. PMID: 8089060


  87. Kanatani MS, Guglielmo BJ. The new macrolides. Azithromycin and clarithromycin. 1994. PMID: 8128699


  88. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Nosocomial funguria: resultant morbidity and therapeutic intervention. 1993. PMID: 8110936


  89. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: a randomized, prospective, blinded clinical study. 1993. PMID: 8413872


  90. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. Comment; ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis. 1993. PMID: 8413895


  91. Colford JM, Corelli RL, Ganz JW, Guglielmo BJ, Jacobs RA. Home antibiotic therapy for streptococcal endocarditis: a call for a controlled trial. 1993. PMID: 8420289


  92. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Treatment of funguria. 1992. PMID: 1578598


  93. Barriere SL, Guglielmo BJ. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. 1992. PMID: 1611812


  94. Corelli RL, Guglielmo BJ, Kapusnik-Uner JE, McMaster JR, Greenblatt RM. Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review. 1991. PMID: 1815436


  95. Glick PL, Guglielmo BJ, Winter ME, Finkbeiner W, Turley K. Iodine toxicity secondary to continuous povidone-iodine mediastinal irrigation in dogs. 1990. PMID: 2246887


  96. Glick M, Guglielmo BJ. Antibiotic prophylaxis in cesarean section. 1990. PMID: 2260343


  97. Hebert MF, Guglielmo BJ. What is the clinical role of aerosolized ribavirin? 1990. PMID: 2197815


  98. Guglielmo BJ, Brooks GF. Antimicrobial therapy. Cost-benefit considerations. 1989. PMID: 2510985


  99. Brodowy BA, Guglielmo BJ, York MK, Herfindal ET, Brooks GF. Experience with selective reporting of susceptibility to antimicrobial agents. 1989. PMID: 2801717


  100. Tam J, Guglielmo BJ. Microbiology and antibiotics in infectious abdominal emergencies. 1989. PMID: 2663459


  101. Guglielmo BJ, Schweigert BF, Kishi DT. Pharmacist-managed drug therapy in California hospitals. 1989. PMID: 2757041


  102. Sue D, Salazar TA, Turley K, Guglielmo BJ. Effect of surgical blood loss and volume replacement on antibiotic pharmacokinetics. 1989. PMID: 2757440


  103. Oliva SL, Guglielmo BJ, Jacobs R, Pons VG. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis. 1989. PMID: 2491408


  104. Guglielmo BJ, Jacobs RA, Locksley RM. The exposure of health care workers to ribavirin aerosol. 1989. PMID: 2926922


  105. Guglielmo BJ, Salazar TA, Rodondi LC, Carver M, Goldstone J, Stoney RJ. Altered pharmacokinetics of antibiotics during vascular surgery. 1989. PMID: 2929864


  106. Dugoni BM, Guglielmo BJ, Hollander H. Amphotericin B concentration in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. 1989. PMID: 2706895


  107. Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG. Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens. 1988. PMID: 3245695


  108. Guglielmo BJ, Rodondi LC. Comparison of antibiotic activities by using serum bactericidal activity over time. 1988. PMID: 3056237


  109. Lam YW, Duroux MH, Gambertoglio JG, Barriere SL, Guglielmo BJ. Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers. 1988. PMID: 3284457


  110. R.J. Harrison, J. Bellows, D. Rempel, L. Rudolph, K. Kizer, A. Jin, B.J. Guglielmo. Assessing Exposures of Health-care Personnel to Aerosols of Ribavirin-California 1988. PMID:


  111. B.J. Guglielmo and L.C. Rodondi. Comparison of Antibiotic Activity Using Serum Bactericidal Activity Over Time 1988. PMID:


  112. Y.W.F. Lam, M.H. Duroux, J.G. Gambertoglio, S.L. Barriere, and B.J. Guglielmo. Effect of Protein Binding on Serum Bactericidal Activities of Ceftazidime and Cefoperazone in Healthy Volunteers 1988. PMID:


  113. P.A. Arnold, B.J. Guglielmo, and H. Hollander. Severe Hypersensitivity Reaction Upon Rechallenge With Trimethoprim-sulfamethoxazole in a Patient With AIDS 1988. PMID:


  114. Arnold PA, Guglielmo BJ, Hollander H. Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS. 1988. PMID: 2965002


  115. M.J. Mahlmeister, B.J. Guglielmo, and R. Harrison. We are Concerned About Ribavirin Exposure 1988. PMID:


  116. Guglielmo BJ, Flaherty JF, Woods TM, LaFollette G, Gambertoglio JG. Pharmacokinetics of cefoperazone and tobramycin alone and in combination. 1987. PMID: 3566252


  117. B.J. Guglielmo, J.F. Flaherty, T.M. Woods, G. LaFollette, and J.G. Gambertoglio. Pharmacokinetics of Cefoperazone and Tobramycin Alone and in Combination 1987. PMID:


  118. Guglielmo BJ, Flaherty JF, Batman R, Barriere SL, Gambertoglio JG. Comparative pharmacokinetics of low- and high-dose ticarcillin. 1986. PMID: 3777901


  119. B.J. Guglielmo, J.F. Flaherty, R. Batman, S.L. Barriere, and J.G. Gambertoglio. Comparative Pharmacokinetics of Low- and High-Dose Ticarcillin 1986. PMID:


  120. Glick PL, Guglielmo BJ, Tranbaugh RF, Turley K. Iodine toxicity in a patient treated by continuous povidone-iodine mediastinal irrigation. 1985. PMID: 3994451


  121. P.L. Glick, B.J. Guglielmo, R.F. Tranbaugh, and K. Turley. Iodine Toxicity in a Patient Treated by Continuous Povidone-Iodine Mediastinal Irrigation 1985. PMID:


  122. B.J. Guglielmo, D.C. Hohn, P.J. Koo, T.K. Hunt, R.C. Sweet, and J.E. Conte. Antibiotic Prophylaxis in Surgical Procedures. A Critical Analysis of the Literature 1983. PMID:


  123. W.A. Kehoe and B.J. Guglielmo. Excessive Potassium Depletion with Metolazone and Furosemide 1983. PMID:


  124. B.D. Quart and B.J. Guglielmo. Prolonged Diarrhea Secondary to Methyldopa Therapy 1983. PMID:


  125. Brown KR, Guglielmo BJ, Pons VG, Jacobs RA. Theophylline elixir, moxalactam, and a disulfiram reaction. 1982. PMID: 6214982


  126. K.R. Brown, B.J. Guglielmo, V.G. Pons, and R.A. Jacobs. Theophylline Elixir, Moxalactam, and a Disulfiram Reaction 1982. PMID:


UCSF Sublogo

 
© 2025 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Medicine                                                                  Accessibility  Privacy Policy  Terms of Use  A-Z Website List